Literature DB >> 20471448

Are gonadotrophins tumorigenic--a critical review of clinical and experimental data.

Ilpo Huhtaniemi1.   

Abstract

The growth of many gonadal and extragonadal tumors is stimulated by gonadal sex hormones. Because gonadal hormone production is regulated by pituitary gonadotrophins, the latter hormones can be considered as indirect tumor promoters. In addition, there is a growing body of evidence that both gonadal (e.g. ovarian cancer) and extragonadal (e.g. breast, uterus, prostate and adrenal) tumors express gonadotrophin receptors, indicating the possibility of a direct tumorigenic role for FSH and LH. The purpose of this brief review is to present a critical evaluation of the current information, both clinical and experimental, about the direct involvement of gonadotrophins in the induction and growth of gonadal and extragonadal tumors.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20471448     DOI: 10.1016/j.mce.2010.04.028

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  18 in total

1.  Follicle Depletion Provides a Permissive Environment for Ovarian Carcinogenesis.

Authors:  Ying Wang; Kathy Qi Cai; Elizabeth R Smith; Toni M Yeasky; Robert Moore; Parvin Ganjei-Azar; Andres J Klein-Szanto; Andrew K Godwin; Thomas C Hamilton; Xiang-Xi Xu
Journal:  Mol Cell Biol       Date:  2016-08-26       Impact factor: 4.272

Review 2.  Differential action of glycoprotein hormones: significance in cancer progression.

Authors:  Vijayakumar Govindaraj; Swathy V Arya; A J Rao
Journal:  Horm Cancer       Date:  2013-10-16       Impact factor: 3.869

3.  The ERK1/2 pathway regulates testosterone synthesis by coordinately regulating the expression of steroidogenic genes in Leydig cells.

Authors:  Maria Eugenia Matzkin; Soichi Yamashita; Mario Ascoli
Journal:  Mol Cell Endocrinol       Date:  2013-03-07       Impact factor: 4.102

4.  LHRH Agonists for the Treatment of Prostate Cancer: 2012.

Authors:  Herbert Lepor; Neal D Shore
Journal:  Rev Urol       Date:  2012

5.  Simultaneous Measurements of Follicle Stimulating Hormone and Total Testosterone and Associations in Clinically Localized Prostate Cancer.

Authors:  Antonio B Porcaro; Salvatore Siracusano; Nicolò de Luyk; Paolo Corsi; Marco Sebben; Alessandro Tafuri; Tania Processali; Davide Inverardi; Giovanni Cacciamani; Daniele Mattevi; Maria A Cerruto; Matteo Brunelli; Claudio Ghimenton; Carmelo Monaco; Walter Artibani
Journal:  Curr Urol       Date:  2017-10-22

6.  Subtype specific elevated expression of hyaluronidase-1 (HYAL-1) in epithelial ovarian cancer.

Authors:  Paule Héléna Yoffou; Lydia Edjekouane; Liliane Meunier; André Tremblay; Diane Michèle Provencher; Anne-Marie Mes-Masson; Euridice Carmona
Journal:  PLoS One       Date:  2011-06-10       Impact factor: 3.240

7.  Regulation of gene expression in ovarian cancer cells by luteinizing hormone receptor expression and activation.

Authors:  Juan Cui; Brooke M Miner; Joanna B Eldredge; Susanne W Warrenfeltz; Phuongan Dam; Ying Xu; David Puett
Journal:  BMC Cancer       Date:  2011-06-28       Impact factor: 4.430

8.  MicroRNA expression and regulation in human ovarian carcinoma cells by luteinizing hormone.

Authors:  Juan Cui; Joanna B Eldredge; Ying Xu; David Puett
Journal:  PLoS One       Date:  2011-07-12       Impact factor: 3.240

Review 9.  Animal models for aberrations of gonadotropin action.

Authors:  Hellevi Peltoketo; Fu-Ping Zhang; Susana B Rulli
Journal:  Rev Endocr Metab Disord       Date:  2011-12       Impact factor: 6.514

10.  Ectopic expression of follicle-stimulating hormone receptors in thyroid tumors.

Authors:  Marek Pawlikowski; Maria Jaranowska; Hanna Pisarek; Robert Kubiak; Julita Fuss-Chmielewska; Katarzyna Winczyk
Journal:  Arch Med Sci       Date:  2015-12-11       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.